JWH-122

From WikiMD's WELLNESSPEDIA


Overview[edit]

JWH-122 is a synthetic cannabinoid that acts as a potent agonist of the cannabinoid receptors. It is part of the naphthoylindole family of compounds and is used in scientific research to study the endocannabinoid system.

Chemical Structure[edit]

Chemical structure of JWH-122

JWH-122 has a chemical structure that includes a naphthoylindole core. The full chemical name is 1-Pentyl-3-(4-methyl-1-naphthoyl)indole. This structure is similar to other synthetic cannabinoids, such as JWH-018 and JWH-073, which also belong to the naphthoylindole class.

Pharmacology[edit]

JWH-122 acts as a full agonist at both the CB1 and CB2 cannabinoid receptors. It has a higher affinity for the CB1 receptor, which is primarily found in the central nervous system. This receptor interaction is responsible for the psychoactive effects associated with cannabinoids.

Effects[edit]

The effects of JWH-122 are similar to those of tetrahydrocannabinol (THC), the primary psychoactive component of cannabis. Users may experience altered perception, mood changes, and cognitive effects. However, as a synthetic compound, JWH-122 can have unpredictable and potentially severe side effects.

Legal Status[edit]

Due to its potential for abuse and lack of medical use, JWH-122 is classified as a controlled substance in many countries. It is often included in legislation targeting synthetic cannabinoids and "designer drugs."

Research[edit]

JWH-122 is used in research to better understand the endocannabinoid system and the effects of cannabinoid receptor activation. Studies often focus on its binding affinity, efficacy, and potential therapeutic applications.

Related pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.